Because the steady-state plasma concentration of SPX in healthy volunteers and patients was 1.8 μM and the hERG IC50 value is 18 μM [16], these results suggest that the slowing of ICaL inactivation may attributable to SPX-induced LQT or arrhythmia under clinical conditions. The gene discussed is SPX; the disease is Arrhythmia.